Victory Capital Management
ENTA icon

Victory Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Victory Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,330
Closed -$899K – 2622
2022
Q3 		$899K Sell
17,330
-1,793
-9% -$105K ﹤0.01% 1782
2022
Q2 		$904K Buy
19,123
+3,009
+19% +$163K ﹤0.01% 1797
2022
Q1 		$1.04M Buy
16,114
+8,657
+116% +$563K ﹤0.01% 1794
2021
Q4 		$558K Buy
+7,457
New +$585K ﹤0.01% 2095
2021
Q2 		– Sell
-5,101
Closed -$252K – 2771
2021
Q1 		$252K Sell
5,101
-1,593
-24% -$79.5K ﹤0.01% 2458
2020
Q4 		$282K Buy
6,694
+677
+11% +$29.8K ﹤0.01% 2299
2020
Q3 		$275K Sell
6,017
-10,043
-63% -$487K ﹤0.01% 2187
2020
Q2 		$806K Buy
16,060
+8,038
+100% +$416K ﹤0.01% 1822
2020
Q1 		$412K Buy
8,022
+3,026
+61% +$161K ﹤0.01% 2149
2019
Q4 		$309K Buy
4,996
+634
+15% +$39.3K ﹤0.01% 2196
2019
Q3 		$262K Buy
4,362
+3,569
+450% +$265K ﹤0.01% 2124
2019
Q2 		$67K Sell
793
-1,377
-63% -$124K ﹤0.01% 1695
2019
Q1 		$207K Sell
2,170
-809
-27% -$72.6K ﹤0.01% 1558
2018
Q4 		$211K Buy
2,979
+116
+4% +$8.89K ﹤0.01% 1545
2018
Q3 		$245K Buy
+2,863
New +$287K ﹤0.01% 1558

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Victory Capital Management's ENTA Position: Q4 2022 in Review

Victory Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q4 2022, closing a stake of 17,330 shares — an estimated $899K sold.

Victory Capital Management first reported a position in ENTA in Q3 2018 and held it in 15 quarters. The position peaked at $1.04M in Q1 2022. 146 funds tracked by Wall St. Rank hold ENTA as of Q4 2022.

  • Victory Capital Management reported no remaining Enanta Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 17,330 Enanta Pharmaceuticals shares in Q4 2022, an estimated $899K.
  • Victory Capital Management first reported a position in Enanta Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Victory Capital Management's Enanta Pharmaceuticals position peaked at $1.04M in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.